XY Planning Network Inc. Purchases Shares of 746 UnitedHealth Group Incorporated (NYSE:UNH)

XY Planning Network Inc. purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 746 shares of the healthcare conglomerate’s stock, valued at approximately $377,000.

A number of other hedge funds have also bought and sold shares of UNH. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $30,000. Finally, AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth $30,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $295.37 on Monday. The company’s 50-day moving average price is $452.40 and its 200-day moving average price is $503.72. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $267.94 billion, a P/E ratio of 19.06, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the prior year, the business posted $6.91 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently issued reports on UNH shares. JPMorgan Chase & Co. lowered their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a report on Thursday, May 15th. Erste Group Bank downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. HSBC reissued a “reduce” rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Wolfe Research lowered their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a report on Tuesday, May 20th. Finally, Barclays decreased their price objective on shares of UnitedHealth Group from $513.00 to $362.00 and set an “overweight” rating on the stock in a report on Thursday, May 15th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $441.87.

Insider Buying and Selling

In other news, CEO Stephen J. Hemsley acquired 86,700 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer now owns 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the business’s stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.